Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Aimmune Therapeutics
Study Determines What Patients Prefer for Maintenance After Completing OIT with...
Dave Bloom
-
2023/01/10
Patients chose from continuing with Palforzia or switching to a common food.
Positive Results from Phase 3 Study of PALFORZIA® in Peanut-Allergic Children...
News Wire ~ 3rd Party Press Release
-
2022/11/11
73.5% of patients treated met the primary outcome at 12 months compared with 6.3% of patients in the placebo arm.
You’re Invited: Patient and Advocacy Educational Presentation by Aimmune Therapeutics
Aimmune
-
2022/10/15
Two events in NJ: Parsippany and Eatontown.
Nestlé Acquires Aimmune, Partners with Enterome to Develop Food Allergy and...
Dave Bloom
-
2022/07/20
Nestlé, the consumer products powerhouse, is expanding its pharmaceutical portfolio with massive investments.
This Holiday Season, See the Potential Impact that Peanut Allergy Treatment...
Aimmune
-
2021/12/07
Did you know there’s a treatment option in addition to avoidance alone?
Notebooks, check. Backpack, check. Peanut allergy treatment, check.
Aimmune
-
2021/10/05
What if you could give your child a treatment option, in addition to practicing a strict peanut-free diet?
Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts...
News Wire ~ 3rd Party Press Release
-
2021/08/05
Safety and efficacy increased over time with treatment.
FARE Launches Global Research Competition to Develop a Safe, Compassionate Diagnostic...
Dave Bloom
-
2021/03/25
$3 Million in prize money will inspire the world's leading food allergy researchers to put an end to the oral food challenge.
Aimmune Presents New Clinical Data From Patients Treated With PALFORZIA® for...
News Wire ~ 3rd Party Press Release
-
2021/02/25
Majority of patients experienced low rates of adverse events which declined in frequency and severity with continued treatment.
Nestlé to Acquire Aimmune Therapeutics
News Wire ~ 3rd Party Press Release
-
2020/08/31
Nestlé Health Science and Aimmune to create a global leader in food allergy prevention and treatment.
1
2
3
...
5
Page 1 of 5